Johnson & Johnson beats by $0.19, beats on revs; reaffirms FY25 EPS guidance, guides FY25 revs above consensus (154.36)
- Reports Q1 (Mar) earnings of $2.77 per share, $0.19 better than the FactSet Consensus of $2.58; revenues rose 2.4% year/year to $21.89 bln vs the $21.56 bln FactSet Consensus.
- Co issues guidance for FY25, sees EPS of $10.50-10.70 vs. $10.46 FactSet Consensus; sees FY25 revs of $91.0-91.8 bln vs. $90.27 bln FactSet Consensus.
- Johnson & Johnson announces that its Board of Directors has declared a 4.8% increase in the quarterly dividend, from $1.24/share to $1.30/share
- At the new rate, the indicated dividend on an annual basis is $5.20 per share compared to the previous rate of $4.96 per share. The next quarterly dividend is payable on June 10, 2025 to shareholders of record at the close of business on May 27, 2025. The ex-dividend date is May 27, 2025.